NAFLD |
nonalcoholic fatty liver disease |
NASH |
nonalcoholic steatohepatitis |
T2DM |
type 2 diabetes mellitus |
ROS |
reactive oxygen species |
IR |
insulin resistance |
CV |
cardiovascular |
LAGB |
laparoscopic gastric banding |
PNPLA |
patatin-like phospholipase domain-containing protein 3 |
HFD |
high fat diet |
WAT |
white adipose tissue |
EDC |
endocrine disrupting compound |
HIF |
hypoxia inducible factor |
TSK |
Tsukushi |
SL |
spleen longitudinal diameter |
LPS |
lipopolisaccaride |
SPX |
splenectomy |
MRglu |
metabolic rate of glucose |
CT |
computerised tomography |
LAL |
lysosomal acid lipase |
VAT |
visceral adipose tissue |
MCD |
methionine and choline deficient |
VitD |
vitamin D |
TG |
triglycerides |
LD |
lipid droplet |
MCP-1 |
monocyte chemotactic protein 1 |
ChREBP |
carbohydrate responsive element binding protein |
DNL |
hepatic de-novo lipogenesis |
AQP |
aquaporin |
DIO |
diet-induced obese |
DPp4 |
dipeptidyl peptidase 4 |
ACE |
angiotensin-converting enzyme |
mTORC |
target of rapamycin complex |
DNA-PK |
DNA-dependent protein kinase |
AMPK |
AMP-activated protein kinase |
IGF-1 |
insulin-like growth factor 1 |
K8/K18 |
keratins 8/keratins 18 |
IRS1 |
insulin receptor substrate1 |
IMCL |
intramyocellular lipid |
MUFA |
monounsaturated fatty acid |
TGF-β |
transforming growth factor-beta |